Charles Zhu
Stock Analyst at LifeSci Capital
(1.52)
# 1437
Out of 5,270 analysts
26
Total ratings
50.00%
Success rate
19.66%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Repare Therapeutics | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Dec 13, 2024 | |
Tango Therapeutics | Maintains: Buy | 18 8 | 1.9 | 321.05% | 3 | Nov 7, 2024 | |
Macrogenics | Upgrades: Buy | 12 | 2.29 | 424.02% | 4 | Nov 7, 2023 | |
Merus | Maintains: Strong Buy | 46 48 | 45.61 | 5.24% | 6 | Aug 8, 2023 | |
Nuvalent | Initiates Coverage On: Buy | 56 | 71.01 | -21.14% | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 22 | 3.44 | 539.53% | 1 | Jul 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 26 | 7.04 | 269.32% | 3 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 32 | 19.09 | 67.63% | 3 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 14 | 12.64 | 10.76% | 2 | May 5, 2022 |